Retrieve available abstracts of 63 articles: HTML format
Single Articles
May 2025
KIM JH, Rim AJ, Miller JT, Jackson M, et al Cardiac Arrest During Long-Distance Running Races.
JAMA. 2025;333:1699-1707. PubMedAbstract available
LEE CJ, Ihm SH, Shin DH, Jeong JO, et al Spironolactone vs Amiloride for Resistant Hypertension: A Randomized Clinical
Trial.
JAMA. 2025 May 14:e255129. doi: 10.1001/jama.2025.5129. PubMedAbstract available
GARRISON SR, Bakal JA, Kolber MR, Korownyk CS, et al Antihypertensive Medication Timing and Cardiovascular Events and Death: The
BedMed Randomized Clinical Trial.
JAMA. 2025 May 12:e254390. doi: 10.1001/jama.2025.4390. PubMedAbstract available
April 2025
PEI YY Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic
Cardiovascular Medications.
JAMA. 2025 Apr 9. doi: 10.1001/jama.2025.0688. PubMed
HO PM, Glorioso TJ, Bull S Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic
Cardiovascular Medications-Reply.
JAMA. 2025 Apr 9. doi: 10.1001/jama.2025.0694. PubMed
YUAN J, Zhao J, Lu K Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic
Cardiovascular Medications.
JAMA. 2025 Apr 9. doi: 10.1001/jama.2025.0691. PubMed
ABRAMOWITZ SA, Levin MG, Damrauer SM Performance and Agreement of Coronary Heart Disease Polygenic Risk Scores-Reply.
JAMA. 2025 Apr 7. doi: 10.1001/jama.2025.0621. PubMed
SHAN D Performance and Agreement of Coronary Heart Disease Polygenic Risk Scores.
JAMA. 2025 Apr 7. doi: 10.1001/jama.2025.0618. PubMed
ANDERER S FDA Updates Testosterone Labeling for Blood Pressure and Cardiovascular Risks.
JAMA. 2025 Apr 4. doi: 10.1001/jama.2025.3240. PubMed
March 2025
KRISHNAN V, Huang X, Perak AM, Coresh J, et al Discordance of 10- and 30-Year Predicted Risk for Cardiovascular Disease in US
Adults.
JAMA. 2025 Mar 31:e252868. doi: 10.1001/jama.2025.2868. PubMed
RODGERS L 7 Takeaways for Primary Care Clinicians From the Updated Acute Coronary Syndromes
Guideline.
JAMA. 2025 Mar 28. doi: 10.1001/jama.2025.2931. PubMed
WU Y, Meng J, Gao S Zerlasiran for the Treatment of Atherosclerotic Cardiovascular Disease.
JAMA. 2025 Mar 27. doi: 10.1001/jama.2025.0031. PubMed
NISSEN SE Zerlasiran for the Treatment of Atherosclerotic Cardiovascular Disease-Reply.
JAMA. 2025 Mar 27. doi: 10.1001/jama.2025.0034. PubMed
NASIR K, Blankstein R Transforming the Cardiovascular Disease Prevention Paradigm: See Disease, Treat
Disease.
JAMA. 2025 Mar 5. doi: 10.1001/jama.2025.2323. PubMed
NERLEKAR N, Vasanthakumar SA, Whitmore K, Soh CH, et al Effects of Combining Coronary Calcium Score With Treatment on Plaque Progression
in Familial Coronary Artery Disease: A Randomized Clinical Trial.
JAMA. 2025 Mar 5:e250584. doi: 10.1001/jama.2025.0584. PubMedAbstract available
February 2025
ANDERER S Supine Hypertension Linked to Cardiovascular Risk Regardless of Seated Blood
Pressure.
JAMA. 2025 Feb 21. doi: 10.1001/jama.2025.0544. PubMed
DEMASI M, Redberg RF, Abramson JD Statins for Primary Prevention of Cardiovascular Disease.
JAMA. 2025 Feb 12. doi: 10.1001/jama.2024.26588. PubMed
LLOYD-JONES DM, Khan S Statins for Primary Prevention of Cardiovascular Disease-Reply.
JAMA. 2025 Feb 12. doi: 10.1001/jama.2024.26594. PubMed
DIAO JA, Wadhera RK, Manrai AK Statins for Primary Prevention of Cardiovascular Disease-Reply.
JAMA. 2025 Feb 12. doi: 10.1001/jama.2024.26591. PubMed
January 2025
WILSON LM, Anderson TS Trends in Preventive Aspirin Use by Atherosclerotic Cardiovascular Risk.
JAMA. 2025 Jan 22. doi: 10.1001/jama.2024.27333. PubMed
HUANG J, Yang J, Liu C, Li L, et al Intra-Arterial Tenecteplase Following Endovascular Reperfusion for Large Vessel
Occlusion Acute Ischemic Stroke: The POST-TNK Randomized Clinical Trial.
JAMA. 2025 Jan 13. doi: 10.1001/jama.2024.23466. PubMedAbstract available
December 2024
ANDERER S Cardiovascular Disease Deaths Climb in Rural US, Particularly Among Younger
Adults.
JAMA. 2024 Dec 20. doi: 10.1001/jama.2024.25507. PubMed
HO PM, Glorioso TJ, Allen LA, Blankenhorn R, et al Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic
Cardiovascular Medications: A Randomized Pragmatic Trial.
JAMA. 2024 Dec 2:e2421739. doi: 10.1001/jama.2024.21739. PubMedAbstract available
November 2024
ABRAMOWITZ SA, Boulier K, Keat K, Cardone KM, et al Evaluating Performance and Agreement of Coronary Heart Disease Polygenic Risk
Scores.
JAMA. 2024 Nov 16:e2423784. doi: 10.1001/jama.2024.23784. PubMedAbstract available
KHAN SS, Pencina MJ Polygenic Risk Scores for Coronary Heart Disease: An Unfulfilled Promise of
Precision Medicine.
JAMA. 2024 Nov 16. doi: 10.1001/jama.2024.24037. PubMed
October 2024
ANDERER S Recalled Cardiovascular Devices Rarely Undergo Sufficient Testing.
JAMA. 2024 Oct 11. doi: 10.1001/jama.2024.20123. PubMed
September 2024
TU WJ, Zhao J Prognostic Value of Cardiovascular Biomarkers.
JAMA. 2024 Sep 18. doi: 10.1001/jama.2024.16519. PubMed
MANGALESH S, Nanna MG Prognostic Value of Cardiovascular Biomarkers.
JAMA. 2024 Sep 18. doi: 10.1001/jama.2024.16522. PubMed
NEUMANN JT, Twerenbold R, Ojeda F Prognostic Value of Cardiovascular Biomarkers-Reply.
JAMA. 2024 Sep 18. doi: 10.1001/jama.2024.16525. PubMed
MENG X, Li S, Dai H, Lu G, et al Tenecteplase vs Alteplase for Patients With Acute Ischemic Stroke: The ORIGINAL
Randomized Clinical Trial.
JAMA. 2024 Sep 12. doi: 10.1001/jama.2024.14721. PubMedAbstract available
August 2024
ANDERER S New Cardiovascular Risk Calculator Could Reduce Blood Pressure Medication
Prescribing.
JAMA. 2024 Aug 16. doi: 10.1001/jama.2024.15514. PubMed
CURFMAN G Chelation Therapy Following Myocardial Infarction.
JAMA. 2024 Aug 14. doi: 10.1001/jama.2024.13549. PubMed
LAMAS GA, Anstrom KJ, Navas-Acien A, Boineau R, et al Edetate Disodium-Based Chelation for Patients With a Previous Myocardial
Infarction and Diabetes: TACT2 Randomized Clinical Trial.
JAMA. 2024 Aug 14:e2411463. doi: 10.1001/jama.2024.11463. PubMedAbstract available
July 2024
KHAN SS, Lloyd-Jones DM Statins for Primary Prevention of Cardiovascular Disease-With PREVENT, What's a
Clinician to Do?
JAMA. 2024 Jul 29. doi: 10.1001/jama.2024.13887. PubMed
GRANT JK, Ndumele CE, Martin SS The Evolving Landscape of Cardiovascular Risk Assessment.
JAMA. 2024 Jul 29. doi: 10.1001/jama.2024.13247. PubMed
DIAO JA, Shi I, Murthy VL, Buckley TA, et al Projected Changes in Statin and Antihypertensive Therapy Eligibility With the AHA
PREVENT Cardiovascular Risk Equations.
JAMA. 2024 Jul 29:e2412537. doi: 10.1001/jama.2024.12537. PubMedAbstract available
GERMAN CA, Davis AM, Polonsky TS Management of Patients With Chronic Coronary Disease.
JAMA. 2024 Jul 24. doi: 10.1001/jama.2024.9813. PubMed
YEH RW, Kirtane AJ Coronary In-Stent Restenosis Treated With Paclitaxel-Coated Balloon vs Uncoated
Balloon-Reply.
JAMA. 2024;332:169-170. PubMed
KRATKA A, Redberg RF Coronary In-Stent Restenosis Treated With Paclitaxel-Coated Balloon vs Uncoated
Balloon.
JAMA. 2024;332:169. PubMed
NICHOLLS SJ, Lam CSP, Nelson AJ Cardiovascular Clinical Trials in the Asia-Pacific Region.
JAMA. 2024 Jul 1. doi: 10.1001/jama.2024.6313. PubMed
June 2024
ANDERER S New Research Could Help Explain Anger's Link to Heart Attacks and Strokes.
JAMA. 2024;331:2065-2066. PubMed
LARKIN H New Cardiovascular Disease Risk Calculator Could Eliminate the Need for Statins
for Millions.
JAMA. 2024 Jun 21. doi: 10.1001/jama.2024.8590. PubMed
May 2024
HARRIS E beta-Blockers After Heart Attacks Might Not Lower Deaths for Some.
JAMA. 2024;331:1698. PubMed
NEUMANN JT, Twerenbold R, Weimann J, Ballantyne CM, et al Prognostic Value of Cardiovascular Biomarkers in the Population.
JAMA. 2024 May 13:e245596. doi: 10.1001/jama.2024.5596. PubMedAbstract available
GAZIANO TA, Gaziano JM Can Cardiovascular Risk Assessment Be Improved in the 21st Century?
JAMA. 2024 May 13. doi: 10.1001/jama.2024.7644. PubMed
SELVARAJ S, Claggett B, Shah SH, Mentz RJ, et al Cardiovascular Burden of the V142I Transthyretin Variant.
JAMA. 2024 May 12:e244467. doi: 10.1001/jama.2024.4467. PubMedAbstract available
AGGARWAL R, Ostrominski JW, Vaduganathan M Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults,
2011-2020.
JAMA. 2024 May 8:e246892. doi: 10.1001/jama.2024.6892. PubMed
April 2024
MCCARTHY CP, Wasfy JH, Januzzi JL Jr Is Myocardial Infarction Overdiagnosed?
JAMA. 2024 Apr 24. doi: 10.1001/jama.2024.5235. PubMed
HARRIS E Study Examines Intermittent Fasting and Cardiovascular Mortality.
JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5158. PubMed
WU F, Jacobs DR Jr, Daniels SR, Kahonen M, et al Non-High-Density Lipoprotein Cholesterol Levels From Childhood to Adulthood and
Cardiovascular Disease Events.
JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.4819. PubMedAbstract available
March 2024
HARRIS E Plastic in Arteries Tied With Higher Risk of Cardiovascular Problems.
JAMA. 2024 Mar 29. doi: 10.1001/jama.2024.3707. PubMed
YEH RW, Shlofmitz R, Moses J, Bachinsky W, et al Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis:
The AGENT IDE Randomized Clinical Trial.
JAMA. 2024;331:1015-1024. PubMedAbstract available
KUNDU A, Moliterno DJ Drug-Coated Balloons for In-Stent Restenosis-Finally Leaving Nothing Behind for
US Patients.
JAMA. 2024;331:1011-1012. PubMed
HARRIS E Meta-Analysis: Cardiovascular Risks Rose After Stopping Aspirin.
JAMA. 2024 Mar 22. doi: 10.1001/jama.2024.2091. PubMed
XU J Sintilimab and Cardiovascular Toxicity-Reply.
JAMA. 2024 Mar 21. doi: 10.1001/jama.2024.0676. PubMed
PENG L, Yang D, Weng C Sintilimab and Cardiovascular Toxicity.
JAMA. 2024 Mar 21. doi: 10.1001/jama.2024.0673. PubMed
CHEN G, Shang M, Yang Y Traditional Chinese Medicine Compound and Clinical Outcomes in Acute Myocardial
Infarction-Reply.
JAMA. 2024 Mar 20. doi: 10.1001/jama.2024.0617. PubMed
ZAKIEV V, Gvozdeva A, Skotnikov A Traditional Chinese Medicine Compound and Clinical Outcomes in Acute Myocardial
Infarction.
JAMA. 2024 Mar 20. doi: 10.1001/jama.2024.0620. PubMed
ASHAM H, Entezari-Maleki T Traditional Chinese Medicine Compound and Clinical Outcomes in Acute Myocardial
Infarction.
JAMA. 2024 Mar 20. doi: 10.1001/jama.2024.0623. PubMed
HARRIS E Blood Test Predicted Risk of Future Heart Attacks.
JAMA. 2024;331:908. PubMed
ANDERER S Cannabis Use Linked to Elevated Myocardial Infarction and Stroke Risk.
JAMA. 2024 Mar 15. doi: 10.1001/jama.2024.2075. PubMed
KO D, Pascual-Leone A, Shah SJ Use of Lecanemab for Patients With Cardiovascular Disease: The Challenge of
Uncertainty.
JAMA. 2024 Mar 15. doi: 10.1001/jama.2024.2991. PubMed
HARRIS E High Niacin Levels May Raise Cardiovascular Disease Risk.
JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1566. PubMed